Sabra Healthcare REIT, Inc. (SBRA) – What Are Researchers Thinking About This Stock?

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has been given a consensus recommendation of “Moderate Buy” by the fourteen research firms that are presently covering the company, MarketBeat reports. Seven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $21.50.

Several equities research analysts have issued reports on the company. Wells Fargo & Company cut their price target on Sabra Healthcare REIT from $23.00 to $21.00 and set an “overweight” rating for the company in a report on Monday, October 19th. Citizens Jmp upped their price objective on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a report on Wednesday, July 22nd. Robert W. Baird increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Monday, August 31st. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Finally, Truist Financial raised their target price on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd.

Insider Buying and Selling

In other Sabra Healthcare REIT news, CEO Richard Matros sold 200,000 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the transaction, the chief executive officer directly owned 1,657,686 shares of the company’s stock, valued at $34,529,599.38. This represents a 10.77% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.09% of the company’s stock.

Institutional Investors Weigh In On Sabra Healthcare REIT

Institutional investors have recently made changes to their positions in the company. Rush Island Management LP bought a new stake in shares of Sabra Healthcare REIT during the 1st quarter valued at $30,735,000. BROOKFIELD Corp ON bought a new position in shares of Sabra Healthcare REIT in the first quarter worth $9,710,000. First Trust Advisors LP raised its stake in Sabra Healthcare REIT by 99.4% in the first quarter. First Trust Advisors LP now owns 750,633 shares of the real estate investment trust’s stock valued at $14,435,000 after purchasing an additional 374,202 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Sabra Healthcare REIT in the second quarter valued at about $6,045,000. Finally, Lasalle Investment Management Securities LLC raised its stake in Sabra Healthcare REIT by 8.2% in the first quarter. Lasalle Investment Management Securities LLC now owns 3,824,622 shares of the real estate investment trust’s stock valued at $73,547,000 after purchasing an additional 290,405 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Performance

SBRA opened at $19.56 on Tuesday. Sabra Healthcare REIT has a 12-month low of $17.17 and a 12-month high of $22.77. The stock has a market cap of $5.00 billion, a price-to-earnings ratio of 75.23, a PEG ratio of 1.78 and a beta of 0.63. The business has a 50 day moving average of $19.97 and a 200-day moving average of $20.06. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.17 by ($0.27). The business had revenue of $230.11 million for the quarter, compared to the consensus estimate of $219.39 million. Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%. The business’s revenue was up 24.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.38 earnings per share. On average, equities research analysts expect that Sabra Healthcare REIT will post 1.52 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were paid a $0.30 dividend. The ex-dividend date was Friday, August 14th. This represents a $1.20 dividend on an annualized basis and a yield of 6.1%. Sabra Healthcare REIT’s dividend payout ratio is 461.54%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.